Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials.
Hollander
Priscilla A
PA
Baylor Endocrine Center, Baylor University Medical Center, Dallas, TX 75246, USA. priscilh@baylorhealth.edu
Krasner
Alan
A
Klioze
Sol
S
Schwartz
Pamela
P
Duggan
William
W
D000280:Administration, Inhalation; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D009656:North America; D012189:Retrospective Studies; D013020:South America
D001786:Blood Glucose; C473734:Exubera; D007328:Insulin